Ceftazidime (WG Critical Care, LLC)


Welcome to the PulseAid listing for the Ceftazidime drug offered from WG Critical Care, LLC. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: WG Critical Care, LLC
NON-PROPRIETARY NAME: Ceftazidime
SUBSTANCE NAME: CEFTAZIDIME
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-26
END MARKETING DATE: 0000-00-00


Ceftazidime HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCeftazidime from WG Critical Care, LLC
LABELER NAME: WG Critical Care, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/20mL)
START MARKETING DATE: 2017-10-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44567-235_e03f50e0-7798-4d9e-a07a-8282c6125c5b
PRODUCT NDC: 44567-235
APPLICATION NUMBER: ANDA062640

Other CEFTAZIDIME Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Ceftazidime and Dextrose
Hospira, Inc.TAZICEF
Sagent PharmaceuticalsCeftazidime
Sandoz IncCeftazidime
WG Critical Care, LLCCeftazidime